A mechanistic physiologically based model to assess the effect of study design and modified physiology on formulation safe space for virtual bioequivalence of dermatological drug products
Physiologically based pharmacokinetic (PBPK) models are widely accepted tools utilised to describe and predict drug pharmacokinetics (PK). This includes the use of dermal PBPK models at the regulatory level including virtual bioequivalence (VBE) studies. The current work considers the Topicort® Spra...
Main Authors: | J. F. Clarke, K. Thakur, S. Polak |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1007496/full |
Similar Items
-
Confocal Raman Spectroscopy for Assessing Bioequivalence of Topical Formulations
by: Fotis Iliopoulos, et al.
Published: (2023-03-01) -
Evaluation of Bioequivalence of Two Long-Acting 20% Oxytetracycline Formulations in Pigs
by: Jiyue Cao, et al.
Published: (2017-05-01) -
Editorial: Pharmacokinetic evaluation and modeling of clinically significant drug metabolites, Volume II
by: Momir Mikov, et al.
Published: (2023-01-01) -
Comparative pharmacokinetic evaluation and bioequivalence study of three different formulations of Imatinib Mesylate in CML patients
by: Ehsan Mohajeri, et al.
Published: (2016-02-01) -
Expert Approaches to the Assessment of Losartan Drugs Bioequivalence
by: D. P. Romodanovsky, et al.
Published: (2020-02-01)